Clinical Trial Update: Year 3 Extension for Efficacy Follow-up in Subjects Vaccinated in Studies Rota-028, 029 or 030 (NCT00197210) [Phase 3]

View source ↗

Summary

Year 3 extension update for efficacy follow-up in subjects vaccinated in GlaxoSmithKline rotavirus vaccine trials Rota-028, Rota-029, and Rota-030 (NCT00197210)…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rotavirus Infection

Drugs mentioned

• Rotarix (Rotavirus vaccine (live attenuated))

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Rotavirus | Phase 3 | Status: COMPLETED | Results posted: 2009-10-14